Equities / Sectors / Healthcare
Healthcare
#6 by market capPharmaceuticals, biotechnology, medical devices and care providers. 564 US-listed equities across 10 industries; the sector accounts for 9.2% of tracked equity market cap and 7.7% of daily volume.
Market cap
$7.664T
+0.04%
$3.007B · 1D
Sector weight
9.2%
of tracked market cap
Volume 24h
$967.8M
7.7% of market volume
Revenue TTM
$4.184T
Sum of constituents
Net income TTM
$153.576B
3.7% net margin
P/E (TTM)
49.6×
Market 30.4×
Dividend yield
1.8%
Market 1.3%
Employees
4.4M
Across 564 companies
Industry breakdown
Share of sector market cap · 10 industries
Concentration
Share of sector market cap by constituent
HHI index
385.9
Mega caps
7
Median cap
$1.398B
Valuation vs. market
Sector totals valued as one company; marker is the all-equities median
P/E (TTM): 49.6× · market 19.9×
P/S: 1.8× · market 2.7×
EV / EBITDA: 19.2× · market 12.9×
Operating margin: 7.9% · market 8.5%
Dividend yield: 1.8% · market 2.3%
Trading at a 63% P/E premium to the all-equities market.
Returns vs. market
Cap-weighted price return · spread in percentage points
| Period | Sector | Market | Spread |
|---|---|---|---|
| 1 day | +0.04% | +0.54% | -0.50% |
| 1 week | -2.41% | +0.34% | -2.74% |
| 1 month | -3.71% | +1.06% | -4.77% |
| 3 months | +0.63% | +2.39% | -1.76% |
| Year to date | +8.37% | +12.38% | -4.01% |
| 1 year | +16.40% | +13.79% | +2.61% |
Constituents
564 equities
Eli Lilly and Company LLY · US | Drug Manufacturers - General | $1.02T | 13.3% | $1.14K | +0.08% | -3.35% | -1.40% | $38.34M | 38.2× |
Johnson & Johnson JNJ · US | Drug Manufacturers - General | $610.245B | 8% | $253.40 | -1.03% | -6.57% | -7.93% | $18.59M | 29× |
AbbVie Inc. ABBV · US | Drug Manufacturers - General | $463.432B | 6% | $262.26 | -0.21% | -0.79% | +0.21% | $13.98M | 73.9× |
Merck & Co., Inc. MRK · US | Drug Manufacturers - General | $343.781B | 4.5% | $139.20 | -3.53% | -6.44% | -8.20% | $18.76M | 38.5× |
UnitedHealth Group Inc. UNH · US | Healthcare Plans | $335.882B | 4.4% | $371.14 | -0.20% | -1.45% | -7.14% | $26.23M | 23.8× |
Thermo Fisher Scientific Inc. TMO · US | Diagnostics & Research | $246.225B | 3.2% | $662.57 | +1.19% | -1.84% | +8.88% | $22.24M | 36× |
Amgen Inc. Common Stock AMGN · US | Drug Manufacturers - General | $215.783B | 2.8% | $399.16 | -0.96% | -3.73% | -9.86% | $21.64M | 24.7× |
Gilead Sciences, Inc. GILD · US | Drug Manufacturers - General | $178.232B | 2.3% | $143.62 | -0.77% | -4.84% | -4.00% | $7.72M | -55× |
Abbott Laboratories ABT · US | Medical Devices | $174.077B | 2.3% | $99.94 | +2.50% | -1.33% | -9.53% | $17.01M | 27.7× |
Pfizer Inc. PFE · US | Drug Manufacturers - General | $155.982B | 2% | $27.37 | -1.55% | -4.53% | -5.69% | $19.92M | 20.8× |
Danaher Corp. DHR · US | Diagnostics & Research | $152.832B | 2% | $217.43 | +1.57% | -3.15% | +3.58% | $9.03M | 38.2× |
Intuitive Surgical Inc. ISRG · US | Medical Instruments & Supplies | $141.935B | 1.9% | $401.06 | +2.32% | -1.02% | +7.85% | $8.34M | 45.2× |
| Biotechnology | $127.211B | 1.7% | $502.12 | -0.52% | -4.57% | -9.81% | $10.09M | 28.9× | |
Bristol-Myers Squibb Company BMY · US | Drug Manufacturers - General | $120.034B | 1.6% | $58.79 | -3.86% | -6.48% | -13.11% | $26.07M | 12.9× |
Medtronic plc MDT · US | Medical Devices | $112.247B | 1.5% | $87.69 | +1.52% | -1.07% | -4.87% | $49.79M | 21.5× |
CVS Health Corporation Common Stock CVS · US | Healthcare Plans | $110.803B | 1.4% | $86.70 | +0.28% | -2.73% | -10.83% | $23.66M | 22.7× |
Stryker Corp. SYK · US | Medical Devices | $108.837B | 1.4% | $283.75 | +3.02% | +4.18% | -9.11% | $17.51M | 29.2× |
McKesson Corporation MCK · US | Medical Distribution | $108.634B | 1.4% | $905.29 | +0.33% | +4.46% | -2.11% | $4.14M | 22.8× |
HCA Healthcare, Inc. HCA · US | Medical Care Facilities | $94.979B | 1.2% | $435.76 | +2.12% | +0.03% | +8.38% | $7.1M | 13.9× |
Elevance Health, Inc. ELV · US | Healthcare Plans | $84.811B | 1.1% | $390.17 | +0.97% | -1.50% | -3.86% | $3.8M | 16.2× |
Moderna Inc. MRNA · US | Biotechnology | $77.661B | 1% | $194.64 | +2.44% | -2.13% | +29.06% | $34.35M | -24.7× |
Regeneron Pharmaceuticals, Inc. REGN · US | Biotechnology | $76.559B | 1% | $729.01 | -0.84% | -7.49% | -14.44% | $8.13M | 17.3× |
The Cigna Group CI · US | Healthcare Plans | $70.871B | 0.9% | $268.83 | -0.63% | -1.17% | -4.95% | $3.69M | 11.1× |
Boston Scientific Corp. BSX · US | Medical Devices | $62.15B | 0.8% | $42.96 | +0.85% | -2.19% | -11.18% | $10.77M | 16.9× |
Natera, Inc. NTRA · US | Diagnostics & Research | $59.771B | 0.8% | $416.20 | +1.43% | +0.88% | +27.99% | $16.96M | -310.8× |